DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
A•• H•••••
H•••••care & Pharmaceuticalsgroup grade Aon a schedule nowsponsor unattributed
Nothing material in the last 200 days. No dated change on record yet.
Mark path, consensus per quarter end
100¢ · 100¢ · 98¢ · 98¢Q3 2025 to Q2 2026
Where each lender marks it, 2 points apart
98¢100¢
Principal held
at least $42.6M
sum of BDC pieces, a lower bound
Fair value
$41.7M
98c on cost, debt pieces
Unfunded
$11.7M
commitments not yet drawn
BDC lenders
5
5 on the latest quarter
Facilities
6
0 equity pieces beside them
Next maturity
Aug 1, 2032
no dated debt inside 24 months
On the tape since
Dec 31, 2024
latest Jun 30, 2026
Events
3
dated, non-routine
Lender marks
each lender's own fair value over cost at Jun 30, 2026, folded to one row per lender
| Lender | Exposure | Current mark | QoQ change |
|---|---|---|---|
| F• K•• C•••••• C••• | $25.4M | 98¢ | +1 pts |
| K•• F• I••••• T•••• | $7.15M | 98¢ | +1 pts |
| A•••• P•••••• C••••• F•••• L•• | $5.11M | 100¢ | +1 pts |
| K•• F• I••••• T•••• S••••• | $4.29M | 98¢ | +1 pts |
| A•••• C••••• B•• I••• | $682K | 100¢ | 0 pts |
Every BDC piece · 32 positions across 5 lenderslargest principal first, with instrument and rate
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| F• K•• C•••••• C••• | unstated lien unstated S••••••• & Services 1 | $17.3M | $16.9M 98c | S+430 bp |
| F• K•• C•••••• C••• | unstated lien unstated S••••••• & Services 3 | $6.0M | $5.8M 97c | S+450 bp |
| A•••• P•••••• C••••• F•••• L•• | term loan first lien Investment T••• U••••••••• T••• L••• I•••• S+ S••••• 4.25% I••••••• R••• 7.98% A••••••••• | $5.1M | $5.1M 100c | SOFR+425 bp |
| K•• F• I••••• T•••• | unstated lien unstated S••••••• & Services 1 | $4.9M | $4.7M 98c | S+430 bp |
| K•• F• I••••• T•••• S••••• | unstated lien unstated S••••••• & Services 1 | $2.9M | $2.8M 98c | S+430 bp |
View all 32 positionsShow fewerlargest principal first
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| F• K•• C•••••• C••• | unstated lien unstated S••••••• & Services 2 | $2.1M | $2.1M 100c | S+450 bp |
| K•• F• I••••• T•••• | unstated lien unstated S••••••• & Services 3 | $1.7M | $1.6M 97c | S+450 bp |
| K•• F• I••••• T•••• S••••• | unstated lien unstated S••••••• & Services 3 | $1.0M | $981,000 97c | S+450 bp |
| K•• F• I••••• T•••• | unstated lien unstated S••••••• & Services 2 | $596,000 | $580,000 97c | S+450 bp |
| A•••• C••••• B•• I••• | term loan first lien Investment T••• U••••••••• T••• L••• I•••• S+ S••••• 4.25% I••••••• R••• 7.98% A••••••••• | $446,960 | $446,960 100c | SOFR+425 bp |
| K•• F• I••••• T•••• S••••• | unstated lien unstated S••••••• & Services 2 | $357,000 | $348,000 97c | S+450 bp |
| A•••• C••••• B•• I••• | term loan first lien Investment T••• U••••••••• T••• L••• I•••• S+ S••••• 4.25% I••••••• R••• 7.98% A••••••••• | $234,840 | $234,840 100c | SOFR+425 bp |
| A•••• C••••• B•• I••• | revolver first lien Investment T••• U••••••••• R••••••• I•••• S+ S••••• 4.50% I••••••• R••• 8.23% A••••••••• D | $0 | $0 0c | SOFR+450 bp |
| A•••• C••••• B•• I••• | revolver first lien Investment T••• U••••••••• R••••••• I•••• S+ S••••• 4.50% I••••••• R••• 8.23% A••••••••• D | $0 | $0 0c | SOFR+450 bp |
| A•••• P•••••• C••••• F•••• L•• | revolver first lien Investment T••• U••••••••• R••••••• I•••• S+ S••••• 4.50% I••••••• R••• 8.23% A••••••••• D | $0 | $0 0c | SOFR+450 bp |
| A•••• P•••••• C••••• F•••• L•• | delayed draw term loan first lien Investment T••• U••••••••• D••• I•••• S+ S••••• 4.50% I••••••• R••• 8.23% A••••••••• D••• | $0 | $0 0c | SOFR+450 bp |
| A•••• P•••••• C••••• F•••• L•• | delayed draw term loan first lien Investment T••• U••••••••• D••• I•••• S+ S••••• 4.50% I••••••• R••• 8.23% A••••••••• D••• | $0 | $0 0c | SOFR+450 bp |
| A•••• C••••• B•• I••• | delayed draw term loan first lien Investment T••• S••••• S•••••• D•••••• D••• T••• L••• I•••• S+ S••••• 4.50% I••••••• R••• | Not disclosed | Not disclosed | SOFR+450 bp |
| A•••• C••••• B•• I••• | delayed draw term loan first lien Investment T••• S••••• S•••••• D•••••• D••• T••• L••• I•••• S+ S••••• 4.50% I••••••• R••• | Not disclosed | Not disclosed | SOFR+425 bp |
| A•••• C••••• B•• I••• | delayed draw term loan first lien Investment T••• U••••••••• D••• I•••• S+ S••••• 4.50% I••••••• R••• 8.23% M••••••• 8/2/203 | Not disclosed | Not disclosed | SOFR+450 bp |
| A•••• C••••• B•• I••• | revolver first lien Investment T••• U••••••••• R••••••• I•••• S+ S••••• 4.50% I••••••• R••• 8.23% M••••••• 8/2 | Not disclosed | Not disclosed | SOFR+450 bp |
| A•••• C••••• B•• I••• | revolver first lien Investment T••• S••••• S•••••• T•••••• A R•••••••• Credit L••• I•••• S+ S••••• 4.50% I•••• | Not disclosed | Not disclosed | SOFR+450 bp |
| A•••• P•••••• C••••• F•••• L•• | delayed draw term loan first lien U••••••••• D••• M••••••• 8/2/2032 | Not disclosed | Not disclosed | SOFR+450 bp |
| A•••• P•••••• C••••• F•••• L•• | delayed draw term loan first lien U••••••••• D••• M••••••• 8/2/2032 One | Not disclosed | Not disclosed | SOFR+450 bp |
| A•••• P•••••• C••••• F•••• L•• | revolver first lien U••••••••• R••••••• M••••••• 8/2/2032 | Not disclosed | Not disclosed | SOFR+450 bp |
| A•••• P•••••• C••••• F•••• L•• | revolver first lien U••••••••• R••••••• M••••••• 8/2/2032 One | Not disclosed | Not disclosed | SOFR+450 bp |
| F• K•• C•••••• C••• | unstated lien unstated | Not disclosed | Not disclosed | |
| F• K•• C•••••• C••• | unstated lien unstated | Not disclosed | Not disclosed | |
| K•• F• I••••• T•••• | unstated lien unstated | Not disclosed | Not disclosed | |
| K•• F• I••••• T•••• | unstated lien unstated | Not disclosed | Not disclosed | |
| K•• F• I••••• T•••• S••••• | unstated lien unstated | Not disclosed | Not disclosed | |
| K•• F• I••••• T•••• S••••• | unstated lien unstated | Not disclosed | Not disclosed |
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| other lien unstated | at least $36.8M | 98c | S+450 bp | Aug 1, 2032 | 3 |
| first lien term loan first lien | at least $5.8M | 100c | SOFR+425 bp | Aug 2, 2032 | 2 |
| first lien revolver first lien | at least $0 | n/a | SOFR+450 bp | Aug 2, 2032 | 2 |
| first lien delayed draw term loan first lien | at least $0 | n/a | SOFR+450 bp | Aug 2, 2032 | 2 |
| delayed draw term loan lien unstated exited Sep 30, 2025 | at least $0 | n/a | SOFR+450 bp | Aug 2, 2032 | 1 |
All 6 facilitiesShow fewerheld first, largest first
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| revolver lien unstated exited Sep 30, 2025 | unknown | n/a | SOFR+450 bp | Aug 2, 2032 | 1 |
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Jun 30, 2026 | 5 | $42.6M | $41.7M | 98c | 0 |
| Mar 31, 2026 | 5 | $42.7M | $41.5M | 98c | 0 |
| Dec 31, 2025 | 5 | $47.7M | $47.7M | 100c | 0 |
| Sep 30, 2025 | 5 | $42.6M | $42.6M | 100c | 0 |
All 5 quartersShow fewer
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Dec 31, 2024 | 2 | $0 | $0 | n/a | 0 |
What changed
- Facility left every BDC scheduleSep 30, 2025
- Facility left every BDC scheduleSep 30, 2025
- New borrower on a BDC scheduleDec 31, 2024
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- A•• H•••••derivedthe codename stem after legal suffixes and deal words
- Spellings
- 1 across 5 BDCsderived
- Industry
- H•••••care & Pharmaceuticalsreportedas one filer wrote it